Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS)
PR97274
Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet
GOES, Netherlands, Aug. 2, 2022 /PRNewswire=KYODO JBN/ --
In the worldwide effort to control monkeypox, a novel and fast typing method to
trace monkeypox virus strains was developed by Dutch company Molecular Biology
Systems (MBS) in collaboration with the department of Medical Microbiology &
Infectious Disease Prevention of the Amsterdam UMC and researchers of the
Danish Rigshospitalet. Apart from being fast, this new method allows for
analysis of multiple samples simultaneously. This way, genetic characterization
of monkeypox virus can be used in source- and contact analyses and help
determine the measures of choice. Analyzing multiple samples simultaneously,
reduces cost per sample, meaning more insight for the same cost. A photo can be
found https://www.nextgenpcr.com/product/mbs-nextgenpcr-ultrafast-thermocycler/:
The method has first been tested in the Amsterdam region; this led to new
insights regarding the genetic diversity of monkeypox virus. This method was
employed investigating the infection of the first child in the Netherlands. The
characterization of mutations in the virus from the child was compared to other
monkeypox viruses in the region. In a publication from July 21, 2022, in the
widely read scientific journal Euro Surveillance the research into this case
and the infectious chain are described. Using source- and contact analyses, no
link with other cases was found. Possibly more undetected infections exist than
assumed until now.
(Publication Euro Surveillance:
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.29.2200552
)
An important bonus of this newly developed typing method is the usability for
other viruses as well. By integrating this technique in source- and contact
surveillance early stage, earlier insight into the spread of novel viruses can
be acquired. This will enable fast, concrete, and accurate action.
The above is in line with the WHO strategy of surveillance of viruses
worldwide, specifically monkeypox. Second meeting of the International Health
Regulations (2005) (IHR) Emergency Committee regarding the multi-country
outbreak of monkeypox (who.int)
Multiple leading international laboratories have indicated their intention to
use this method for the genomic surveillance of monkeypox.
About Molecular Biology Systems
Molecular Biology Systems, B.V., founded in 2015, is a molecular biology
solutions company based in the Netherlands. Our NextGenPCR thermocycler uses
patented technology to reduce PCR amplification from hours to minutes.
NextGenPCR, the PCR technology of the future, available now.
Website: https://www.nextgenpcr.com/
Source: Molecular Biology Systems
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。